Hims & Hers Health's stock has surged 205% since my last 'Buy' rating, but its valuation is now stretched, prompting a downgrade to 'Hold'. Some risks include Amazon's aggressive telehealth entry and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback